The McGill Centre for Microbiome Research leadership thanks the External Advisory Board members for their commitment to our research initiative. We are grateful for the opportunity to share expertise and experiences with esteemed local and international colleagues to foster innovation in microbiome research for the benefit of the scientific community and populations.
Ìý
Colin Hill has a Ph.D. in molecular microbiology and is a Professor in the School of Microbiology at University College Cork, Ireland. He is also a founding Principal Investigator in APC Microbiome Ireland, a large research Centre devoted to the study of the role of the gut microbiota in health and disease. He is particularly interested in the effects of probiotics, bacteriocins, and bacteriophage. He has published more than 600 papers and holds 25 patents. He was president of ISAPP from 2012-2015. More than 80 PhD students have been trained in his laboratory.
Ìý
To learn more about Dr Hill's research, click on the following links:
Ìý
Rana Samadfam received both her MSc and PhD in pharmacology from the Université de Sherbrooke. Following her successful postdoctoral training at Ï㽶ÊÓƵ, Rana joined Charles River Laboratories in 2006. Dr. Samadfam is a Diplomate of the American Board of Toxicology. She is the recipient of several scientific awards, author of over 125 peer-reviewed publications. Her team has extensive experience in microbiome research with particular focus in conducting efficacy studies with live therapeutics.
Ìý
To learn more about Dr Samadfam's research, clink on the following links:
Ìý
Elena Verdu obtained a medical degree in Argentina and then pursued a Ph.D. degree in immunology and gnotobiology at the Czech Academy of Science on the effect of commensal bacterial antigens in inflammatory bowel disease and celiac disease. In 2006 Dr. Verdu was appointed faculty at McMaster University, where she developed a program to investigate dietary-microbial-host interactions in gastroenterology. Her research aims at deciphering commensal and opportunistic pathogen metabolism of dietary antigens and how that process affects their inflammatory capacity in the host. She is director of the Axenic and Gnotobiotic facility, Associate Director of the Farncombe Institute at McMaster, and Senior Associate Editor (basic Science) for the journal Gastroenterology. Currently she holds the rank of full professor and a Tier Canada Research Chair in Microbial Therapeutics and Nutrition in Gastroenterology.
To learn more about Dr Verdu's research, click on the following links:
Ìý
Iliyan Iliev is an Immunologist and an Associate Professor at the Department of Medicine and the Jill Roberts Institute for Research in IBD at Weill Cornell Medical College, Cornell University, New York. Iliyan Iliev’ s pioneering research on the gut mycobiota defined a role of commensal fungi in innate mucosal and protective humoral immunity and provided evidence for mycobiota involvement in the pathophysiology of Inflammatory Bowel Disease (IBD). The laboratory applies translational, experimental and computational approaches to study the role of immunity to mycobiota early and later in life, upon therapeutic interventions and during conditions, such as inflammatory bowel disease, allergy, gastrointestinal and lung cancers, and immunodeficiencies, where fungi contribute to pathologies.
To learn more about Dr Iliev's research, click on the following links:
Ìý
